
Shortened treatment benefits some with pre-extensively drug-resistant TB, but not all
A shortened, all-oral drug regimen worked well for some patients with pre-extensively drug-resistant tuberculosis (pre-XDR TB), according to the results of a multi-country randomized controlled trial published this week in The Lancet Respiratory Medicine. …